Evaluation of WSS and Neointimal Healing Following Percutaneous Coronary Intervention of Angulated Vessels With Resolute® Integrity Zotarolimus Eluting Coronary Stent Compared to XIENCE Xpedition® Everolimus Eluting Coronary Stent
Phase of Trial: Phase III
Latest Information Update: 28 Jan 2019
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms SHEAR-STENT
- 28 Jan 2019 Last check against ClinicalTrials.gov: US National Institutes of Health
- 22 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Jun 2020.
- 22 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2020.